Abpro Holdings, Inc. (ABPO)
Designs engineered antibodies that attack cancer cells and eye diseases.
$0.19+0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-97.3%
The outlook
ABPO is trading near its 52-week low, well below both its 50- and 200-day moving averages, reflecting sustained downward pressure. Analyst coverage is thin, and the stock's StockGlow score sits at the bearish end of the spectrum. The extremely low trailing P/E suggests either distressed valuation metrics or limited profitability data.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range1% of the way from its 52-week low to high
Market cap
$1.1M
52-wk high
$10.86
52-wk low
$0.09
50-day avg
$0.21
200-day avg
$2.21
Trailing P/E
0.3